PortfoliosLab logo
Im Cannabis Corp (IMCC)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

CA44969Q2080

CUSIP

449923101

IPO Date

May 20, 2020

Highlights

Market Cap

$5.46M

EPS (TTM)

-$3.26

Total Revenue (TTM)

$41.97M

Gross Profit (TTM)

$6.67M

EBITDA (TTM)

-$3.97M

Year Range

$1.55 - $1.85

Target Price

$8.22

Short %

0.64%

Short Ratio

1.21

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
IMCC vs. CRON IMCC vs. VIG
Popular comparisons:

Performance

Performance Chart


Loading data...

Returns By Period


IMCC

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

-3.77%

1M

5.53%

6M

-5.60%

1Y

8.37%

5Y*

14.61%

10Y*

10.35%

*Annualized

Monthly Returns

The table below presents the monthly returns of IMCC, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20254.42%4.42%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of IMCC is 16, meaning it’s performing worse than 84% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of IMCC is 1616
Overall Rank
The Sharpe Ratio Rank of IMCC is 1919
Sharpe Ratio Rank
The Sortino Ratio Rank of IMCC is 1717
Sortino Ratio Rank
The Omega Ratio Rank of IMCC is 1919
Omega Ratio Rank
The Calmar Ratio Rank of IMCC is 1111
Calmar Ratio Rank
The Martin Ratio Rank of IMCC is 1414
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Im Cannabis Corp (IMCC) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


There isn't enough data available to calculate the Sharpe ratio for Im Cannabis Corp. This metric is based on the past 12 months of trading data. Please check back later for updated information.


Loading data...

Dividends

Dividend History


Im Cannabis Corp doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Im Cannabis Corp. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Im Cannabis Corp was 6.25%, occurring on May 9, 2025. The portfolio has not yet recovered.

The current Im Cannabis Corp drawdown is 6.25%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-6.25%May 7, 20253May 9, 2025

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Im Cannabis Corp over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Im Cannabis Corp, comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 59.3% positive surprise.


-20.00-15.00-10.00-5.000.0020212022202320242025
-0.23
-0.54
Actual
Estimate

Valuation

The Valuation section provides an overview of how Im Cannabis Corp is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for IMCC relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, IMCC has a P/S ratio of 0.1. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for IMCC in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, IMCC has a P/B value of 1.4. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items